Opportunities and risks in a rapidly evolving market.
Previously purely used by healthcare institutions, genetic testing can now be undertaken cheaply, quickly and directly by consumers as a result of rapid technological advancement over the last decade.
The market for direct-to-consumer genetic testing (DTC-GT), in which end-users order sampling kits directly, is forecast to grow steadily to be worth over $1 billion by 2020. However, commercial success for new and more established players is not guaranteed. Tightening regulations and growing concerns over data privacy, scientific accuracy and the psychological impact on consumers, demands careful consideration.
Key insights in this report include:
Drivers of growth
Data privacy concerns